Reveleer to Demonstrate AI’s Transformative Impact on Value-Based Care at ViVE 2025

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Leading value-based care platform accelerates into 2025 with strong momentum and plans for continued growth.

GLENDALE, Calif., Feb. 13, 2025 /PRNewswire/ — Reveleer, the leading value-based care enablement platform, will demonstrate AI-powered, intelligent automation solutions at ViVE, taking place February 16-19, 2025.

Featuring its Evidence Validation Engine (EVE™), Reveleer’s platform unifies and transforms structured, semi-structured, and unstructured clinical data — such as notes, test results, and medical histories — into clinical insights. These insights intelligently automate and power workflows to improve efficiency, enhance patient care, and strengthen financial performance. By making sense of vast amounts of healthcare data, we help clinicians and health plans work together more effectively, keeping the focus where it belongs – delivering better patient care.

Reveleer solidified its leadership in artificial intelligence healthcare solutions in 2024 hitting significant milestones, including:

  • Processed 1.1 billion pages of clinical data helping payers and providers manage vast amounts of information with unparalleled efficiency.
  • Achieved an industry-leading accuracy rate of 99% through our proprietary AI-scoring model.
  • Facilitated the validation of over 2.5 million diagnoses showcasing its ability to use artificial intelligence to enhance clinical accuracy and scale.
  • Onboarded 25 new customers expanding its reach and impact across the healthcare ecosystem.

“Reveleer is transforming how payers and providers harness clinical data to drive better decisions and outcomes,” said Jay Ackerman, CEO of Reveleer. “Our AI-powered technology aggregates and analyzes patient data across care settings, delivering a complete, transparent view of the patient’s journey. More than just insights, our solutions take the next best action to intelligently automate and optimize value-based care workflows — driving efficiency, accuracy, and measurable ROI.”

ViVE attendees will have the opportunity to experience live demos of Reveleer’s risk, quality, and clinical intelligence solutions, and learn about how our intelligent automation optimizes workflows across the risk continuum.

To learn more about Reveleer, stop by booth 538 at ViVE 2025 or visit reveleer.com.

About Reveleer
As the industry’s pioneering value-based care (VBC) enablement platform, Reveleer is purpose-built to solve the most pressing real-world challenges faced by provider and health-plan organizations today. By unifying retrieval, clinical intelligence, risk adjustment, quality improvement, and member management solutions into one intelligent, AI powered system, Reveleer streamlines fragmented workflows to supercharge productivity, enhance care quality, and optimize performance on high-priority value-based initiatives. To learn more about Reveleer’s value-based care platform, visit us at Reveleer.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/reveleer-to-demonstrate-ais-transformative-impact-on-value-based-care-at-vive-2025-302375669.html

SOURCE Reveleer

Staff

Recent Posts

cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion

Charlotte, North Carolina--(Newsfile Corp. - April 21, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

26 minutes ago

Onsite Mammography Provides Notice of Data Incident

BOSTON, April 21, 2025 /PRNewswire/ -- Onsite Mammography ("Onsite") announces a data incident that impacted…

3 hours ago

Lumenis Unveils Enhanced SPLENDOR X™ Laser Hair Removal Solution with New Clinical Data at the Annual American Society for Laser Medicine and Surgery (ASLMS) Conference

New data demonstrates effectiveness of SPLENDOR X™'s dual-wavelength simultaneous laser emission technology for improved hair…

3 hours ago

Havas Health Network and Republica Havas Health Unveil Report on Inequities in HCP Training and Practices

"The Hidden Divide" Exposes Gaps in Healthcare Provider Education and Care Delivery MIAMI, April 21,…

9 hours ago

K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate with Ultra-High Drug Loading Capacity Demonstrates Superior Efficacy in EGFR-Expressing Solid Tumors

NAGOYA, Japan, April 21, 2025 /PRNewswire/ -- Kowa Company, Ltd. (Headquarters: Nagoya, Aichi Prefecture, Japan), today announced…

9 hours ago

Zimmer Biomet Completes Acquisition of Paragon 28

Transaction Further Strengthens Company's Position in High-Growth Foot and Ankle Segment WARSAW, Ind., April 21, 2025…

9 hours ago